Literature DB >> 32910920

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.

Jiandong Huo, Yuguang Zhao, Jingshan Ren, Daming Zhou, Helen M E Duyvesteyn, Helen M Ginn, Loic Carrique, Tomas Malinauskas, Reinis R Ruza, Pranav N M Shah, Tiong Kit Tan, Pramila Rijal, Naomi Coombes, Kevin R Bewley, Julia A Tree, Julika Radecke, Neil G Paterson, Piyada Supasa, Juthathip Mongkolsapaya, Gavin R Screaton, Miles Carroll, Alain Townsend, Elizabeth E Fry, Raymond J Owens, David I Stuart.   

Abstract

Entities:  

Year:  2020        PMID： 32910920      PMCID： PMC7480219          DOI： 10.1016/j.chom.2020.07.002

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN： 1931-3128            Impact factor:   21.023


× No keyword cloud information.
  19 in total

Review 1.  Antibody-mediated neutralization of SARS-CoV-2.

Authors:  Henning Gruell; Kanika Vanshylla; Timm Weber; Christopher O Barnes; Christoph Kreer; Florian Klein
Journal:  Immunity       Date:  2022-05-13       Impact factor: 43.474

2.  Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry.

Authors:  Young-Jun Park; Anna De Marco; Tyler N Starr; Zhuoming Liu; Dora Pinto; Alexandra C Walls; Fabrizia Zatta; Samantha K Zepeda; John E Bowen; Kaitlin R Sprouse; Anshu Joshi; Martina Giurdanella; Barbara Guarino; Julia Noack; Rana Abdelnabi; Shi-Yan Caroline Foo; Laura E Rosen; Florian A Lempp; Fabio Benigni; Gyorgy Snell; Johan Neyts; Sean P J Whelan; Herbert W Virgin; Jesse D Bloom; Davide Corti; Matteo Samuele Pizzuto; David Veesler
Journal:  Science       Date:  2022-01-06       Impact factor: 63.714

3.  Identification of a Novel Neutralizing Epitope on the N-Terminal Domain of the Human Coronavirus 229E Spike Protein.

Authors:  Jiale Shi; Yuejun Shi; Ruixue Xiu; Gang Wang; Rui Liang; Yuzhou Jiao; Zhou Shen; Chengliang Zhu; Guiqing Peng
Journal:  J Virol       Date:  2021-12-15       Impact factor: 6.549

Review 4.  Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

Authors:  William R Strohl; Zhiqiang Ku; Zhiqiang An; Stephen F Carroll; Bruce A Keyt; Lila M Strohl
Journal:  BioDrugs       Date:  2022-04-27       Impact factor: 7.744

5.  Modeling in the Time of COVID-19: Statistical and Rule-based Mesoscale Models.

Authors:  Ngan Nguyen; Ondrej Strnad; Tobias Klein; Deng Luo; Ruwayda Alharbi; Peter Wonka; Martina Maritan; Peter Mindek; Ludovic Autin; David S Goodsell; Ivan Viola
Journal:  IEEE Trans Vis Comput Graph       Date:  2021-01-28       Impact factor: 4.579

6.  A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.

Authors:  Tiong Kit Tan; Pramila Rijal; Rolle Rahikainen; Anthony H Keeble; Lisa Schimanski; Saira Hussain; Ruth Harvey; Jack W P Hayes; Jane C Edwards; Rebecca K McLean; Veronica Martini; Miriam Pedrera; Nazia Thakur; Carina Conceicao; Isabelle Dietrich; Holly Shelton; Anna Ludi; Ginette Wilsden; Clare Browning; Adrian K Zagrajek; Dagmara Bialy; Sushant Bhat; Phoebe Stevenson-Leggett; Philippa Hollinghurst; Matthew Tully; Katy Moffat; Chris Chiu; Ryan Waters; Ashley Gray; Mehreen Azhar; Valerie Mioulet; Joseph Newman; Amin S Asfor; Alison Burman; Sylvia Crossley; John A Hammond; Elma Tchilian; Bryan Charleston; Dalan Bailey; Tobias J Tuthill; Simon P Graham; Helen M E Duyvesteyn; Tomas Malinauskas; Jiandong Huo; Julia A Tree; Karen R Buttigieg; Raymond J Owens; Miles W Carroll; Rodney S Daniels; John W McCauley; David I Stuart; Kuan-Ying A Huang; Mark Howarth; Alain R Townsend
Journal:  Nat Commun       Date:  2021-01-22       Impact factor: 14.919

7.  Spectroscopic investigation on the affinity of SARS-CoV-2 spike protein to gold nano-particles.

Authors:  Kazushige Yokoyama; Akane Ichiki
Journal:  Colloid Interface Sci Commun       Date:  2020-12-26

8.  Rotavirus as an Expression Platform of Domains of the SARS-CoV-2 Spike Protein.

Authors:  Asha Ann Philip; John Thomas Patton
Journal:  Vaccines (Basel)       Date:  2021-05-03

9.  Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2.

Authors:  Alexandra C Walls; Brooke Fiala; Alexandra Schäfer; Samuel Wrenn; Minh N Pham; Michael Murphy; Longping V Tse; Laila Shehata; Megan A O'Connor; Chengbo Chen; Mary Jane Navarro; Marcos C Miranda; Deleah Pettie; Rashmi Ravichandran; John C Kraft; Cassandra Ogohara; Anne Palser; Sara Chalk; E-Chiang Lee; Elizabeth Kepl; Cameron M Chow; Claire Sydeman; Edgar A Hodge; Brieann Brown; Jim T Fuller; Kenneth H Dinnon; Lisa E Gralinski; Sarah R Leist; Kendra L Gully; Thomas B Lewis; Miklos Guttman; Helen Y Chu; Kelly K Lee; Deborah H Fuller; Ralph S Baric; Paul Kellam; Lauren Carter; Marion Pepper; Timothy P Sheahan; David Veesler; Neil P King
Journal:  bioRxiv       Date:  2020-08-12

10.  A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface.

Authors:  Charlie Nichols; Joseph Ng; Annika Keshu; Franca Fraternali; Gian F De Nicola
Journal:  Front Pharmacol       Date:  2020-12-14       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.